CELL SURFACE RECEPTORS ON CYTOTOXIC T CELLS
细胞毒性 T 细胞上的细胞表面受体
基本信息
- 批准号:6124161
- 负责人:
- 金额:$ 23.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1978
- 资助国家:美国
- 起止时间:1978-08-01 至 2001-11-30
- 项目状态:已结题
- 来源:
- 关键词:CD3 molecule T cell receptor biological signal transduction calcineurin cytotoxic T lymphocyte guanine nucleotide binding protein laboratory mouse laboratory rabbit leukocyte activation /transformation mitogen activated protein kinase phosphatidylinositol 3 kinase protein kinase C tissue /cell culture transfection yeast two hybrid system
项目摘要
In response to antigen recognition, resting T lymphocytes undergo a complex
series of events known as T-cell activation that initiates signal
transduction pathways leading to T cell proliferation, activation induced
cell death, cytokine production, or cytolysis. However, T cell antigen
receptor (TCR/CD3) signaling is not sufficient to control activation of
resting T cells: co-stimulatory signals through for instance CD4/8,
CD28/CTLA4 need to be provided. Although much has been learned about
T-cell activation, an orderly array of the molecular events involved in the
whole process remains to be established. Immediately following T-cell
antigen recognition the CD3 proteins recruit non-receptor-protein-tyrosine
kinases to phosphorylate the CD3 Immunerceptor Tyrosine Activation Motifs
(ITAMS). The four principal pathways that potentially ensue upon
tyrosinephosphorylation of the CD3 ITAMs are: the MAP-kinase pathways, the
Calcineurin pathway, a PKC and a PI3'-kinase pathway. We will concentrate
our efforts on the biochemical reactions which couple CD3-zeta and
CD3-epsilon to the MAP kinase pathways. Regulation of the early
biochemical steps from CD3-epsilon and CD3-zeta towards Ras and the Rho
family GTP binding proteins appear to be critical in the precise control
of T cell activation. Our general hypothesis is that most of the
biochemical events that regulate responsiveness to antigens are proximal
to the CD3 proteins. Specifically we propose to:
-Analyze the initial biochemical steps leading from CD3-zeta or CD3-
epsilon to Ras in the activation of the MAP kinase Raf-1.
-Test the hypothesis that the 14.3.3/CD3-zeta complex provides a
scaffold upon which some of the pathways between CD3-zeta and Raf are
initiated.
-Test the hypothesis that a Rho family GTP binding protein complexes with
CD3-zeta to activate the MAP-kinases JNK and p38.
-Further study the in vitro TCR signal transduction in peripheral CD4 plus
and CD8 plus T lymphocytes from CD3-zeta/eta null mice.
作为对抗原识别的反应,静止的T淋巴细胞经历了一种复合体
一系列称为T细胞激活的事件,启动信号
诱导T细胞增殖、活化的信号转导途径
细胞死亡、细胞因子产生或细胞溶解。然而,T细胞抗原
受体(TCR/CD3)信号不足以控制细胞的激活
静息T细胞:通过例如CD4/8的共刺激信号,
需要提供CD28/CTLA4。尽管人们已经了解了很多关于
T细胞激活,一系列有序的分子事件参与
整个过程还有待确定。紧跟在T细胞之后
CD3蛋白募集非受体蛋白酪氨酸的抗原识别
磷酸化CD3免疫受体酪氨酸激活基序的激酶
(ITAMS)。可能随之而来的四条主要途径
CD3ITAM的酪氨酸磷酸化是:MAP-K通路,
钙调神经磷酸酶途径、PKC和PI3‘-激酶途径。我们会集中精力
我们在CD3-Zeta和CD3-Zeta偶联的生化反应方面的努力
CD3-epsilon到MAP激酶通路。对早期的监管
从CD3-epsilon和CD3-Zeta到RAS和Rho的生化步骤
家族GTP结合蛋白似乎在精确控制中起关键作用
T细胞的激活。我们的一般假设是,大多数
调节对抗原的反应性的生化事件是最近的
CD3蛋白。具体来说,我们建议:
-分析CD3-Zeta或CD3-的初始生化步骤-
Epsilon以RAS激活MAP激酶Raf-1。
-检验14.3.3/CD3-Zeta复合体提供
CD3-Zeta和Raf之间的一些通路的脚手架
已启动。
-测试Rho家族GTP结合蛋白与
CD3-Zeta激活MAP-Kinase JNK和p38。
-进一步研究外周血中TCR信号转导
CD3-Zeta/ETA缺失小鼠的CD8+T淋巴细胞。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CORNELIS P TERHORST其他文献
CORNELIS P TERHORST的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CORNELIS P TERHORST', 18)}}的其他基金
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response
影响免疫反应特定阶段的原发性免疫缺陷
- 批准号:
8296689 - 财政年份:2009
- 资助金额:
$ 23.98万 - 项目类别:
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response
影响免疫反应特定阶段的原发性免疫缺陷
- 批准号:
7560933 - 财政年份:2009
- 资助金额:
$ 23.98万 - 项目类别:
Role of SAP (SH2D1A) gene in T cell-dependent antibody response
SAP (SH2D1A) 基因在 T 细胞依赖性抗体反应中的作用
- 批准号:
7614096 - 财政年份:2009
- 资助金额:
$ 23.98万 - 项目类别:
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response
影响免疫反应特定阶段的原发性免疫缺陷
- 批准号:
7882569 - 财政年份:2009
- 资助金额:
$ 23.98万 - 项目类别:
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response
影响免疫反应特定阶段的原发性免疫缺陷
- 批准号:
8102821 - 财政年份:2009
- 资助金额:
$ 23.98万 - 项目类别:
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response
影响免疫反应特定阶段的原发性免疫缺陷
- 批准号:
8501241 - 财政年份:2009
- 资助金额:
$ 23.98万 - 项目类别:
SLAM Gene Family Controlled Pathways to SLE
SLAM 基因家族控制 SLE 通路
- 批准号:
7275918 - 财政年份:2006
- 资助金额:
$ 23.98万 - 项目类别:
相似海外基金
The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
- 批准号:
DP240102905 - 财政年份:2024
- 资助金额:
$ 23.98万 - 项目类别:
Discovery Projects
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23K28188 - 财政年份:2024
- 资助金额:
$ 23.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
- 批准号:
2339172 - 财政年份:2024
- 资助金额:
$ 23.98万 - 项目类别:
Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
- 批准号:
10577518 - 财政年份:2023
- 资助金额:
$ 23.98万 - 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23H03498 - 财政年份:2023
- 资助金额:
$ 23.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
- 批准号:
10676407 - 财政年份:2023
- 资助金额:
$ 23.98万 - 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
- 批准号:
22KK0277 - 财政年份:2023
- 资助金额:
$ 23.98万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
- 批准号:
10599584 - 财政年份:2023
- 资助金额:
$ 23.98万 - 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
- 批准号:
10530023 - 财政年份:2022
- 资助金额:
$ 23.98万 - 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
- 批准号:
10684172 - 财政年份:2022
- 资助金额:
$ 23.98万 - 项目类别:














{{item.name}}会员




